Targeting MRI remission in RA, specifically targeting osteitis, did not confer benefit over clinical T2T over 2 years. Maybe our clinical examination is not so bad afterall @steverheum_hall
@RheumNow ABST0890 #ACR22
https://t.co/8nUjWQONyk https://t.co/xGzZNLiJ7U
Links:
Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Diseas…
https://tinyurl.com/2p89n2hu
13-11-2022
